ESTRO 36 Programme book and exhibition guide

> Secondary cancer risk after particle therapy for organs distal or lateral to the target volume L. Toussaint (Denmark), L. Muren, G. Engeseth, C. Stokkevåg > Deriving HPV status from standard CT imaging: a radiomic approach with independent validation R. Leijenaar (The Netherlands), M. Nesteruk, G. Feliciani, F. Hoebers, J. Van Timmeren, W. Van Elmpt, S. Walsh, A. Jochems, S. Huang, B. Chan, J. Waldron, B. O’Sullivan, D. Rietveld, C. Leemans, O. Riesterer, K. Ikenberg, P. Lambin > Tolerance doses for detailed late effects after prostate cancer radiotherapy – a post-QUANTEC review C. Olsson (Sweden), M. Thor, J.O. Deasy > Predictors for morbidity from planned vs. delivered rectal dose maps in RT of prostate cancer J. Trane, O. Casares Magaz (Denmark), L. Bentzen, K. Busch, M. Thor, L.P. Muren > Dose-response relationships for radiation-induced urgency syndrome after gynecological radiotherapy E. Alevronta (Sweden), V. Skokic, U. Wilderäng, G. Dunberger, F. Sjöberg, C. Bull, K. Bergmark, G. Steineck > Estimates of the α/β ratio for prostate using data from recent hypofractionated RT trials. S. Gulliford (UK), C. Griffin, A. Tree, J. Murray, U. Oelfke, I. Syndikus, E. Hall, D. Dearnaley > Modelling DNA damage on gold nanoparticle enhanced proton therapy M. Sotiropoulos (UK), N.T. Henthorn, J.W. Warmenhoven, R.I. Mackay, K.J. Kirkby, M.J. Merchant > Uncertainty of dose-volume constraints obtained from radiation pneumonitis dose-response analysis C.M. Lutz (Denmark), D.S. Møller, L. Hoffmann, A.A. Khalil, M.M. Knap, M. Alber > Second cancer risk after radiation of localized prostate cancer with and without flattening filter M. Treutwein (Germany), M. Hipp, R. Loeschel, O. Koelbl, B. Dobler

EP-1607

ELECTRONIC POSTERS

EP-1608

EP-1609

EP-1610

EP-1611

EP-1612

EP-1613

EP-1614

EP-1615

POSTERS AND ELECTRONIC POSTERS | Programme and Exhibition Guide

288